Pentraxin-3 as a poor marker of fibrosis in metabolic dysfunction-associated steatotic liver disease among older adults: findings from the PolSenior2 substudy

Pentraxin-3 as a poor marker of fibrosis in metabolic dysfunction-associated steatotic liver disease among older adults: findings from the PolSenior2 substudy

IntroductionThe study aimed to assess the relationship between plasma pentraxin 3 (PTX-3) levels and the potential diagnosis of fibrosis in metabolic dysfunction-associated steatohepatitis (MASH) in older adults. This was assessed using the Fibrosis-4 index (FIB-4), NAFLD fibrosis score (NFS), and H...

Full description

Saved in:
Bibliographic Details
Main Authors: Aleksander Jerzy Owczarek, Joanna Musialik, Adrian Stefański, Małgorzata Mossakowska, Katarzyna Zięba, Andrzej Więcek, Jerzy Chudek, Magdalena Olszanecka-Glinianowicz
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-02-01
Series:Frontiers in Medicine
Subjects:
PTX-3
FIB-4
MASLD
fibrosis
NASH
the elderly population
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2025.1445973/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2025.1445973/full

Similar Items